View ValuationAlzChem Group 향후 성장Future 기준 점검 4/6AlzChem Group (는) 각각 연간 19.1% 및 11.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 19% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 27% 로 예상됩니다.핵심 정보19.1%이익 성장률18.97%EPS 성장률Chemicals 이익 성장43.5%매출 성장률11.2%향후 자기자본이익률27.00%애널리스트 커버리지Good마지막 업데이트07 May 2026최근 향후 성장 업데이트공시 • May 02AlzChem Group AG Confirms Earnings Guidance for the Fiscal Year 2025AlzChem Group AG confirmed earnings guidance for the fiscal year 2025. For the year, the Group sales are expected to grow by approximately 5% compared with the previous year.Price Target Changed • Oct 23Price target increased by 13% to €71.78Up from €63.65, the current price target is an average from 4 analysts. New target price is 24% above last closing price of €57.80. Stock is up 196% over the past year. The company is forecast to post earnings per share of €4.97 for next year compared to €3.40 last year.Price Target Changed • Oct 11Price target increased by 7.7% to €66.03Up from €61.30, the current price target is an average from 4 analysts. New target price is 22% above last closing price of €54.20. Stock is up 170% over the past year. The company is forecast to post earnings per share of €4.92 for next year compared to €3.40 last year.Price Target Changed • Aug 19Price target increased by 13% to €61.30Up from €54.05, the current price target is an average from 4 analysts. New target price is 18% above last closing price of €52.00. Stock is up 154% over the past year. The company is forecast to post earnings per share of €4.93 for next year compared to €3.40 last year.Price Target Changed • Aug 06Price target increased by 7.5% to €56.05Up from €52.15, the current price target is an average from 4 analysts. New target price is 21% above last closing price of €46.30. Stock is up 148% over the past year. The company is forecast to post earnings per share of €4.52 for next year compared to €3.40 last year.Price Target Changed • Jul 30Price target increased by 9.4% to €54.05Up from €49.40, the current price target is an average from 4 analysts. New target price is 9.2% above last closing price of €49.50. Stock is up 159% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €3.40 last year.모든 업데이트 보기Recent updates공시 • Mar 25AlzChem Group AG, Annual General Meeting, May 05, 2026AlzChem Group AG, Annual General Meeting, May 05, 2026, at 10:00 W. Europe Standard Time.공시 • Feb 28AlzChem Group AG announces Annual dividend, payable on May 08, 2026AlzChem Group AG announced Annual dividend of EUR 2.1000 per share payable on May 08, 2026, ex-date on May 06, 2026 and record date on May 07, 2026.공시 • Nov 06+ 3 more updatesAlzChem Group AG to Report Q3, 2026 Results on Oct 30, 2026AlzChem Group AG announced that they will report Q3, 2026 results on Oct 30, 2026공시 • Sep 24AlzChem Group AG to Report Q3, 2025 Results on Oct 30, 2025AlzChem Group AG announced that they will report Q3, 2025 results on Oct 30, 2025공시 • May 09AlzChem Group AG to Report First Half, 2025 Results on Jul 30, 2025AlzChem Group AG announced that they will report first half, 2025 results on Jul 30, 2025공시 • May 02AlzChem Group AG Confirms Earnings Guidance for the Fiscal Year 2025AlzChem Group AG confirmed earnings guidance for the fiscal year 2025. For the year, the Group sales are expected to grow by approximately 5% compared with the previous year.공시 • Mar 29AlzChem Group AG, Annual General Meeting, May 08, 2025AlzChem Group AG, Annual General Meeting, May 08, 2025, at 10:00 W. Europe Standard Time.공시 • Dec 06Alzchem Group Ag Appoints Martina Spitzer as A New Member of the Management Board, Effective from January 1, 2025AlzChem Group AG approved the appointment of Martina Spitzer as a new member of the Management Board for a term of three years from January 1, 2025 to December 31, 2027. In her new position as Chief Sales Officer (CSO), she will be responsible for the areas of Health & Nutrition (Creapure®), Fine Chemicals (Chemicals & Applications) and Sustainability (ESG). Ms. Spitzer’s appointment as CSO represents the next important step in the early succession planning for the Management Board. Ms. Spitzer is now already taking over two important business areas in sales, as Dr. Weichselbaumer will be in charge of the future project of setting up production in the USA. Ms. Spitzer has been with the Alzchem Group since 1999. In 2020, she was appointed Head of Alzchem’s entire chemical sales division, before she shifted her focus to strategic corporate development and ESG in 2022 after around 15 years in sales. In this role, she was instrumental in the introduction of the sustainability division, the optimization of central business processes and the implementation of forward-looking projects.공시 • Nov 27AlzChem Group AG to Report Q1, 2025 Results on Apr 30, 2025AlzChem Group AG announced that they will report Q1, 2025 results on Apr 30, 2025Reported Earnings • Nov 09Third quarter 2024 earnings released: EPS: €1.22 (vs €0.85 in 3Q 2023)Third quarter 2024 results: EPS: €1.22 (up from €0.85 in 3Q 2023). Revenue: €132.7m (up 7.0% from 3Q 2023). Net income: €12.4m (up 44% from 3Q 2023). Profit margin: 9.3% (up from 7.0% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.공시 • Nov 08AlzChem Group AG to Report Fiscal Year 2024 Results on Feb 28, 2025AlzChem Group AG announced that they will report fiscal year 2024 results on Feb 28, 2025Price Target Changed • Oct 23Price target increased by 13% to €71.78Up from €63.65, the current price target is an average from 4 analysts. New target price is 24% above last closing price of €57.80. Stock is up 196% over the past year. The company is forecast to post earnings per share of €4.97 for next year compared to €3.40 last year.Price Target Changed • Oct 11Price target increased by 7.7% to €66.03Up from €61.30, the current price target is an average from 4 analysts. New target price is 22% above last closing price of €54.20. Stock is up 170% over the past year. The company is forecast to post earnings per share of €4.92 for next year compared to €3.40 last year.Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €52.40, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 150% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.85 per share.Buy Or Sell Opportunity • Sep 30Now 23% overvaluedOver the last 90 days, the stock has fallen 1.9% to €47.30. The fair value is estimated to be €38.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 10% in 2 years. Earnings are forecast to grow by 23% in the next 2 years.Valuation Update With 7 Day Price Move • Sep 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €41.50, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 91% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.38 per share.Price Target Changed • Aug 19Price target increased by 13% to €61.30Up from €54.05, the current price target is an average from 4 analysts. New target price is 18% above last closing price of €52.00. Stock is up 154% over the past year. The company is forecast to post earnings per share of €4.93 for next year compared to €3.40 last year.Price Target Changed • Aug 06Price target increased by 7.5% to €56.05Up from €52.15, the current price target is an average from 4 analysts. New target price is 21% above last closing price of €46.30. Stock is up 148% over the past year. The company is forecast to post earnings per share of €4.52 for next year compared to €3.40 last year.Reported Earnings • Aug 02Second quarter 2024 earnings released: EPS: €0.71 (vs €0.70 in 2Q 2023)Second quarter 2024 results: EPS: €0.71 (up from €0.70 in 2Q 2023). Revenue: €139.9m (up 5.2% from 2Q 2023). Net income: €14.4m (up 100% from 2Q 2023). Profit margin: 10% (up from 5.4% in 2Q 2023). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.공시 • Aug 02AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024AlzChem Group AG announced that they will report Q3, 2024 results on Nov 07, 2024Price Target Changed • Jul 30Price target increased by 9.4% to €54.05Up from €49.40, the current price target is an average from 4 analysts. New target price is 9.2% above last closing price of €49.50. Stock is up 159% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €3.40 last year.New Risk • Jul 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.0% average weekly change).Price Target Changed • May 15Price target increased by 15% to €49.40Up from €43.10, the current price target is an average from 4 analysts. New target price is 12% above last closing price of €44.00. Stock is up 122% over the past year. The company is forecast to post earnings per share of €4.03 for next year compared to €3.40 last year.공시 • May 09AlzChem Group AG to Report First Half, 2024 Results on Aug 01, 2024AlzChem Group AG announced that they will report first half, 2024 results on Aug 01, 2024Reported Earnings • May 01First quarter 2024 earnings released: EPS: €1.20 (vs €0.76 in 1Q 2023)First quarter 2024 results: EPS: €1.20 (up from €0.76 in 1Q 2023). Revenue: €153.6m (up 1.4% from 1Q 2023). Net income: €12.2m (up 59% from 1Q 2023). Profit margin: 7.9% (up from 5.1% in 1Q 2023). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €43.50, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 101% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.69 per share.Declared Dividend • Mar 28Dividend increased to €1.20Dividend of €1.20 is 14% higher than last year. Ex-date: 8th May 2024 Payment date: 10th May 2024 Dividend yield will be 3.2%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (35% earnings payout ratio) and cash flows (23% cash payout ratio). The dividend has increased by an average of 1.5% per year over the past 6 years. However, payments have been volatile during that time. EPS is expected to grow by 40% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Price Target Changed • Mar 07Price target increased by 7.9% to €37.35Up from €34.63, the current price target is an average from 4 analysts. New target price is 25% above last closing price of €30.00. Stock is up 60% over the past year. The company is forecast to post earnings per share of €3.83 for next year compared to €3.40 last year.Price Target Changed • Mar 04Price target increased by 7.9% to €35.60Up from €33.00, the current price target is an average from 4 analysts. New target price is 31% above last closing price of €27.10. Stock is up 38% over the past year. The company is forecast to post earnings per share of €3.77 for next year compared to €3.40 last year.Price Target Changed • Dec 05Price target increased by 9.1% to €34.63Up from €31.75, the current price target is an average from 4 analysts. New target price is 40% above last closing price of €24.70. Stock is up 36% over the past year. The company is forecast to post earnings per share of €3.51 for next year compared to €2.96 last year.공시 • Nov 30AlzChem Group AG to Report Q1, 2024 Results on Apr 30, 2024AlzChem Group AG announced that they will report Q1, 2024 results on Apr 30, 2024Price Target Changed • Nov 10Price target increased by 9.3% to €33.00Up from €30.20, the current price target is an average from 4 analysts. New target price is 42% above last closing price of €23.30. Stock is up 40% over the past year. The company is forecast to post earnings per share of €3.31 for next year compared to €2.96 last year.New Risk • Oct 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.5% average weekly change).Reported Earnings • Oct 29Third quarter 2023 earnings released: EPS: €0.85 (vs €0.58 in 3Q 2022)Third quarter 2023 results: EPS: €0.85 (up from €0.58 in 3Q 2022). Revenue: €123.9m (down 15% from 3Q 2022). Net income: €8.61m (up 45% from 3Q 2022). Profit margin: 7.0% (up from 4.1% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.공시 • Oct 27AlzChem Group AG to Report Fiscal Year 2023 Results on Mar 01, 2024AlzChem Group AG announced that they will report fiscal year 2023 results on Mar 01, 2024공시 • Sep 19AlzChem Group AG to Report Q3, 2023 Results on Oct 26, 2023AlzChem Group AG announced that they will report Q3, 2023 results on Oct 26, 2023Valuation Update With 7 Day Price Move • Aug 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €22.00, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in Germany. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.19 per share.New Risk • Aug 04New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 42% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (42% net debt to equity). Dividend is not well covered by cash flows (138% cash payout ratio).Reported Earnings • Aug 03Second quarter 2023 earnings released: EPS: €0.71 (vs €0.95 in 2Q 2022)Second quarter 2023 results: EPS: €0.71 (down from €0.95 in 2Q 2022). Revenue: €128.5m (down 14% from 2Q 2022). Net income: €7.20m (down 25% from 2Q 2022). Profit margin: 5.6% (down from 6.5% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • May 06First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: EPS: €0.76 (down from €0.76 in 1Q 2022). Revenue: €156.0m (up 19% from 1Q 2022). Net income: €7.67m (flat on 1Q 2022). Profit margin: 4.9% (down from 5.9% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.1%. Earnings per share (EPS) also surpassed analyst estimates by 23%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.공시 • May 05AlzChem Group AG to Report First Half, 2023 Results on Aug 03, 2023AlzChem Group AG announced that they will report first half, 2023 results on Aug 03, 2023Upcoming Dividend • May 05Upcoming dividend of €1.05 per share at 5.5% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. Payout ratio is a comfortable 35% but the company is not cash flow positive. Trailing yield: 5.5%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).Price Target Changed • Mar 21Price target increased by 8.7% to €29.58Up from €27.20, the current price target is an average from 4 analysts. New target price is 57% above last closing price of €18.85. Stock is down 21% over the past year. The company posted earnings per share of €2.96 last year.Reported Earnings • Mar 01Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €2.96 (up from €2.72 in FY 2021). Revenue: €566.4m (up 32% from FY 2021). Net income: €30.1m (up 8.9% from FY 2021). Profit margin: 5.3% (down from 6.4% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to €17.85, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 12x in the Chemicals industry in Germany. Total loss to shareholders of 10% over the past three years.공시 • Dec 09AlzChem Group AG, Annual General Meeting, May 11, 2023AlzChem Group AG, Annual General Meeting, May 11, 2023, at 10:00 Central European Standard Time.Price Target Changed • Nov 16Price target decreased to €26.05Down from €29.43, the current price target is an average from 4 analysts. New target price is 55% above last closing price of €16.85. Stock is down 28% over the past year. The company is forecast to post earnings per share of €2.40 for next year compared to €2.72 last year.Reported Earnings • Oct 28Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: €0.59 (up from €0.46 in 3Q 2021). Revenue: €145.1m (up 48% from 3Q 2021). Net income: €5.93m (up 27% from 3Q 2021). Profit margin: 4.1% (down from 4.8% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 18%. Earnings per share (EPS) also surpassed analyst estimates by 69%. Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.공시 • Oct 27AlzChem Group AG to Report Fiscal Year 2022 Final Results on Feb 28, 2023AlzChem Group AG announced that they will report fiscal year 2022 final results at 9:00 AM, Central European Standard Time on Feb 28, 2023Price Target Changed • Oct 20Price target decreased to €26.05Down from €29.43, the current price target is an average from 4 analysts. New target price is 73% above last closing price of €15.05. Stock is down 33% over the past year. The company is forecast to post earnings per share of €2.55 for next year compared to €2.72 last year.Reported Earnings • Jul 27Second quarter 2022 earnings released: EPS: €0.95 (vs €0.90 in 2Q 2021)Second quarter 2022 results: EPS: €0.95 (up from €0.90 in 2Q 2021). Revenue: €142.4m (up 26% from 2Q 2021). Net income: €9.59m (up 4.5% from 2Q 2021). Profit margin: 6.7% (down from 8.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 8.7%, compared to a 7.3% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • May 11First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.76 (down from €0.78 in 1Q 2021). Revenue: €133.5m (up 25% from 1Q 2021). Net income: €7.70m (down 2.4% from 1Q 2021). Profit margin: 5.8% (down from 7.4% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 9.9%. Over the next year, revenue is forecast to grow 8.7%, compared to a 6.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Upcoming Dividend • Apr 29Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 06 May 2022. Payment date: 10 May 2022. Payout ratio is a comfortable 37% and this is well supported by cash flows. Trailing yield: 4.5%. Within top quartile of German dividend payers (4.0%). In line with average of industry peers (4.9%).Reported Earnings • Feb 25Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: €2.72 (up from €1.94 in FY 2020). Revenue: €433.7m (up 12% from FY 2020). Net income: €27.6m (up 40% from FY 2020). Profit margin: 6.4% (up from 5.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 4.1%, compared to a 6.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS €0.46 (vs €0.37 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €98.1m (up 17% from 3Q 2020). Net income: €4.69m (up 25% from 3Q 2020). Profit margin: 4.8% (up from 4.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Price Target Changed • Aug 09Price target increased to €32.25Up from €28.50, the current price target is an average from 2 analysts. New target price is 31% above last closing price of €24.70. Stock is up 23% over the past year.Reported Earnings • Aug 06Second quarter 2021 earnings released: EPS €0.66 (vs €0.66 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €113.5m (up 6.5% from 2Q 2020). Net income: €9.17m (up 37% from 2Q 2020). Profit margin: 8.1% (up from 6.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year and the company’s share price has also fallen by 6% per year.Reported Earnings • May 07First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €108.3m (up 13% from 1Q 2020). Net income: €7.89m (up 80% from 1Q 2020). Profit margin: 7.3% (up from 4.6% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Upcoming Dividend • May 06Upcoming dividend of €0.77 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 18 May 2021. Trailing yield: 3.1%. Within top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).Reported Earnings • Mar 20Full year 2020 earnings released: EPS €1.94 (vs €1.77 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €389.9m (up 1.3% from FY 2019). Net income: €19.7m (up 9.6% from FY 2019). Profit margin: 5.1% (up from 4.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Feb 25New 90-day high: €24.50The company is up 19% from its price of €20.60 on 27 November 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €43.68 per share.공시 • Jan 16AlzChem Group AG to Report Fiscal Year 2020 Results on Mar 19, 2021AlzChem Group AG announced that they will report fiscal year 2020 results on Mar 19, 2021Analyst Estimate Surprise Post Earnings • Nov 12Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 16%. Over the next year, revenue is forecast to grow 4.9%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.Reported Earnings • Nov 12Third quarter 2020 earnings released: EPS €0.37The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: €84.1m (down 18% from 3Q 2019). Net income: €3.76m (down 25% from 3Q 2019). Profit margin: 4.5% (down from 4.9% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 78% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.공시 • Nov 07AlzChem Group AG Expands Nitrile Production by 50%AlzChem Group AG consistently continues its growth and investment strategy even in the current environment. Due to the continuing high level of market demand, nitrile production will be expanded by up to 50% by the second quarter of 2021. The investment volume amounts to approximately EUR 12 million. The currently available capacities had only been expanded as of July 2019 and quickly reached 100% capacity. The additional nitrile production capacities are intended to primarily support the growth of medications and biocides. AlzChem takes advantage of the market trend towards more robust supply chains, thus following the trend of increased supply security through a European supplier. The expanded nitrile production plant is again based on AlzChem's proven gas phase technology, which is continuously being optimized by AlzChem engineers and chemists and which sets the standards in terms of raw material yield and environmental aspects.Is New 90 Day High Low • Oct 30New 90-day low: €17.50The company is down 4.0% from its price of €18.15 on 31 July 2020. The German market is also down 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.80 per share.공시 • Oct 15AlzChem Group AG Revises Consolidated Sales Guidance for the Fiscal Year 2020AlzChem Group AG revised consolidated sales guidance for the fiscal year 2020. Due to the continuing economic effects of the COVID-19 pandemic in individual target industries and regions, AlzChem Group AG adjusts its forecast for fiscal year 2020. The company now expects to generate stable to slightly declining consolidated sales compared to the previous year (original forecast: slightly rising to sharply rising).공시 • Oct 01+ 1 more updateAlzChem Group AG to Report First Half, 2021 Results on Aug 05, 2021AlzChem Group AG announced that they will report first half, 2021 results on Aug 05, 2021공시 • Sep 12AlzChem Group AG to Report Q1, 2021 Results on May 06, 2021AlzChem Group AG announced that they will report Q1, 2021 results on May 06, 2021이익 및 매출 성장 예측DB:ACT - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202881510894118512/31/202770587-1489612/31/202660667114563/31/2026581674125N/A12/31/20255756339137N/A9/30/202557662102146N/A6/30/20255685869113N/A3/31/20255595672121N/A12/31/20245635462105N/A9/30/20245645082103N/A6/30/2024555467697N/A3/31/2024546397396N/A12/31/2023546355273N/A9/30/2023533302555N/A6/30/2023554282453N/A3/31/202357030-1512N/A12/31/202255030-33-4N/A9/30/202253429-254N/A6/30/202248728-280N/A3/31/202245427329N/A12/31/2021429281443N/A9/30/2021420271140N/A6/30/2021406263463N/A3/31/2021397231448N/A12/31/2020386202049N/A9/30/2020370161052N/A6/30/2020389171153N/A3/31/2020387172054N/A12/31/201938518N/A44N/A9/30/201938919N/A42N/A6/30/201938018N/A22N/A3/31/201938020N/A33N/A12/31/201838323N/A35N/A9/30/201838022N/A24N/A6/30/201839832N/A31N/A3/31/201836421N/A23N/A12/31/201736120N/A31N/A9/30/201735622N/A31N/A12/31/201633315N/A33N/A9/30/201633112N/A39N/A12/31/201532915N/A30N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: ACT 의 연간 예상 수익 증가율(19.1%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: ACT 의 연간 수익(19.1%)이 German 시장(17.1%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: ACT 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: ACT 의 수익(연간 11.2%)이 German 시장(연간 6.8%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: ACT 의 수익(연간 11.2%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: ACT의 자본 수익률은 3년 후 27%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 17:07종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스AlzChem Group AG는 8명의 분석가가 다루고 있습니다. 이 중 6명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchGerhard OrgonasBerenberg5명의 분석가 더 보기
공시 • May 02AlzChem Group AG Confirms Earnings Guidance for the Fiscal Year 2025AlzChem Group AG confirmed earnings guidance for the fiscal year 2025. For the year, the Group sales are expected to grow by approximately 5% compared with the previous year.
Price Target Changed • Oct 23Price target increased by 13% to €71.78Up from €63.65, the current price target is an average from 4 analysts. New target price is 24% above last closing price of €57.80. Stock is up 196% over the past year. The company is forecast to post earnings per share of €4.97 for next year compared to €3.40 last year.
Price Target Changed • Oct 11Price target increased by 7.7% to €66.03Up from €61.30, the current price target is an average from 4 analysts. New target price is 22% above last closing price of €54.20. Stock is up 170% over the past year. The company is forecast to post earnings per share of €4.92 for next year compared to €3.40 last year.
Price Target Changed • Aug 19Price target increased by 13% to €61.30Up from €54.05, the current price target is an average from 4 analysts. New target price is 18% above last closing price of €52.00. Stock is up 154% over the past year. The company is forecast to post earnings per share of €4.93 for next year compared to €3.40 last year.
Price Target Changed • Aug 06Price target increased by 7.5% to €56.05Up from €52.15, the current price target is an average from 4 analysts. New target price is 21% above last closing price of €46.30. Stock is up 148% over the past year. The company is forecast to post earnings per share of €4.52 for next year compared to €3.40 last year.
Price Target Changed • Jul 30Price target increased by 9.4% to €54.05Up from €49.40, the current price target is an average from 4 analysts. New target price is 9.2% above last closing price of €49.50. Stock is up 159% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €3.40 last year.
공시 • Mar 25AlzChem Group AG, Annual General Meeting, May 05, 2026AlzChem Group AG, Annual General Meeting, May 05, 2026, at 10:00 W. Europe Standard Time.
공시 • Feb 28AlzChem Group AG announces Annual dividend, payable on May 08, 2026AlzChem Group AG announced Annual dividend of EUR 2.1000 per share payable on May 08, 2026, ex-date on May 06, 2026 and record date on May 07, 2026.
공시 • Nov 06+ 3 more updatesAlzChem Group AG to Report Q3, 2026 Results on Oct 30, 2026AlzChem Group AG announced that they will report Q3, 2026 results on Oct 30, 2026
공시 • Sep 24AlzChem Group AG to Report Q3, 2025 Results on Oct 30, 2025AlzChem Group AG announced that they will report Q3, 2025 results on Oct 30, 2025
공시 • May 09AlzChem Group AG to Report First Half, 2025 Results on Jul 30, 2025AlzChem Group AG announced that they will report first half, 2025 results on Jul 30, 2025
공시 • May 02AlzChem Group AG Confirms Earnings Guidance for the Fiscal Year 2025AlzChem Group AG confirmed earnings guidance for the fiscal year 2025. For the year, the Group sales are expected to grow by approximately 5% compared with the previous year.
공시 • Mar 29AlzChem Group AG, Annual General Meeting, May 08, 2025AlzChem Group AG, Annual General Meeting, May 08, 2025, at 10:00 W. Europe Standard Time.
공시 • Dec 06Alzchem Group Ag Appoints Martina Spitzer as A New Member of the Management Board, Effective from January 1, 2025AlzChem Group AG approved the appointment of Martina Spitzer as a new member of the Management Board for a term of three years from January 1, 2025 to December 31, 2027. In her new position as Chief Sales Officer (CSO), she will be responsible for the areas of Health & Nutrition (Creapure®), Fine Chemicals (Chemicals & Applications) and Sustainability (ESG). Ms. Spitzer’s appointment as CSO represents the next important step in the early succession planning for the Management Board. Ms. Spitzer is now already taking over two important business areas in sales, as Dr. Weichselbaumer will be in charge of the future project of setting up production in the USA. Ms. Spitzer has been with the Alzchem Group since 1999. In 2020, she was appointed Head of Alzchem’s entire chemical sales division, before she shifted her focus to strategic corporate development and ESG in 2022 after around 15 years in sales. In this role, she was instrumental in the introduction of the sustainability division, the optimization of central business processes and the implementation of forward-looking projects.
공시 • Nov 27AlzChem Group AG to Report Q1, 2025 Results on Apr 30, 2025AlzChem Group AG announced that they will report Q1, 2025 results on Apr 30, 2025
Reported Earnings • Nov 09Third quarter 2024 earnings released: EPS: €1.22 (vs €0.85 in 3Q 2023)Third quarter 2024 results: EPS: €1.22 (up from €0.85 in 3Q 2023). Revenue: €132.7m (up 7.0% from 3Q 2023). Net income: €12.4m (up 44% from 3Q 2023). Profit margin: 9.3% (up from 7.0% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Nov 08AlzChem Group AG to Report Fiscal Year 2024 Results on Feb 28, 2025AlzChem Group AG announced that they will report fiscal year 2024 results on Feb 28, 2025
Price Target Changed • Oct 23Price target increased by 13% to €71.78Up from €63.65, the current price target is an average from 4 analysts. New target price is 24% above last closing price of €57.80. Stock is up 196% over the past year. The company is forecast to post earnings per share of €4.97 for next year compared to €3.40 last year.
Price Target Changed • Oct 11Price target increased by 7.7% to €66.03Up from €61.30, the current price target is an average from 4 analysts. New target price is 22% above last closing price of €54.20. Stock is up 170% over the past year. The company is forecast to post earnings per share of €4.92 for next year compared to €3.40 last year.
Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €52.40, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 150% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.85 per share.
Buy Or Sell Opportunity • Sep 30Now 23% overvaluedOver the last 90 days, the stock has fallen 1.9% to €47.30. The fair value is estimated to be €38.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 10% in 2 years. Earnings are forecast to grow by 23% in the next 2 years.
Valuation Update With 7 Day Price Move • Sep 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €41.50, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 91% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.38 per share.
Price Target Changed • Aug 19Price target increased by 13% to €61.30Up from €54.05, the current price target is an average from 4 analysts. New target price is 18% above last closing price of €52.00. Stock is up 154% over the past year. The company is forecast to post earnings per share of €4.93 for next year compared to €3.40 last year.
Price Target Changed • Aug 06Price target increased by 7.5% to €56.05Up from €52.15, the current price target is an average from 4 analysts. New target price is 21% above last closing price of €46.30. Stock is up 148% over the past year. The company is forecast to post earnings per share of €4.52 for next year compared to €3.40 last year.
Reported Earnings • Aug 02Second quarter 2024 earnings released: EPS: €0.71 (vs €0.70 in 2Q 2023)Second quarter 2024 results: EPS: €0.71 (up from €0.70 in 2Q 2023). Revenue: €139.9m (up 5.2% from 2Q 2023). Net income: €14.4m (up 100% from 2Q 2023). Profit margin: 10% (up from 5.4% in 2Q 2023). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Aug 02AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024AlzChem Group AG announced that they will report Q3, 2024 results on Nov 07, 2024
Price Target Changed • Jul 30Price target increased by 9.4% to €54.05Up from €49.40, the current price target is an average from 4 analysts. New target price is 9.2% above last closing price of €49.50. Stock is up 159% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €3.40 last year.
New Risk • Jul 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.0% average weekly change).
Price Target Changed • May 15Price target increased by 15% to €49.40Up from €43.10, the current price target is an average from 4 analysts. New target price is 12% above last closing price of €44.00. Stock is up 122% over the past year. The company is forecast to post earnings per share of €4.03 for next year compared to €3.40 last year.
공시 • May 09AlzChem Group AG to Report First Half, 2024 Results on Aug 01, 2024AlzChem Group AG announced that they will report first half, 2024 results on Aug 01, 2024
Reported Earnings • May 01First quarter 2024 earnings released: EPS: €1.20 (vs €0.76 in 1Q 2023)First quarter 2024 results: EPS: €1.20 (up from €0.76 in 1Q 2023). Revenue: €153.6m (up 1.4% from 1Q 2023). Net income: €12.2m (up 59% from 1Q 2023). Profit margin: 7.9% (up from 5.1% in 1Q 2023). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €43.50, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 101% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.69 per share.
Declared Dividend • Mar 28Dividend increased to €1.20Dividend of €1.20 is 14% higher than last year. Ex-date: 8th May 2024 Payment date: 10th May 2024 Dividend yield will be 3.2%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (35% earnings payout ratio) and cash flows (23% cash payout ratio). The dividend has increased by an average of 1.5% per year over the past 6 years. However, payments have been volatile during that time. EPS is expected to grow by 40% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Price Target Changed • Mar 07Price target increased by 7.9% to €37.35Up from €34.63, the current price target is an average from 4 analysts. New target price is 25% above last closing price of €30.00. Stock is up 60% over the past year. The company is forecast to post earnings per share of €3.83 for next year compared to €3.40 last year.
Price Target Changed • Mar 04Price target increased by 7.9% to €35.60Up from €33.00, the current price target is an average from 4 analysts. New target price is 31% above last closing price of €27.10. Stock is up 38% over the past year. The company is forecast to post earnings per share of €3.77 for next year compared to €3.40 last year.
Price Target Changed • Dec 05Price target increased by 9.1% to €34.63Up from €31.75, the current price target is an average from 4 analysts. New target price is 40% above last closing price of €24.70. Stock is up 36% over the past year. The company is forecast to post earnings per share of €3.51 for next year compared to €2.96 last year.
공시 • Nov 30AlzChem Group AG to Report Q1, 2024 Results on Apr 30, 2024AlzChem Group AG announced that they will report Q1, 2024 results on Apr 30, 2024
Price Target Changed • Nov 10Price target increased by 9.3% to €33.00Up from €30.20, the current price target is an average from 4 analysts. New target price is 42% above last closing price of €23.30. Stock is up 40% over the past year. The company is forecast to post earnings per share of €3.31 for next year compared to €2.96 last year.
New Risk • Oct 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.5% average weekly change).
Reported Earnings • Oct 29Third quarter 2023 earnings released: EPS: €0.85 (vs €0.58 in 3Q 2022)Third quarter 2023 results: EPS: €0.85 (up from €0.58 in 3Q 2022). Revenue: €123.9m (down 15% from 3Q 2022). Net income: €8.61m (up 45% from 3Q 2022). Profit margin: 7.0% (up from 4.1% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
공시 • Oct 27AlzChem Group AG to Report Fiscal Year 2023 Results on Mar 01, 2024AlzChem Group AG announced that they will report fiscal year 2023 results on Mar 01, 2024
공시 • Sep 19AlzChem Group AG to Report Q3, 2023 Results on Oct 26, 2023AlzChem Group AG announced that they will report Q3, 2023 results on Oct 26, 2023
Valuation Update With 7 Day Price Move • Aug 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €22.00, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in Germany. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.19 per share.
New Risk • Aug 04New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 42% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (42% net debt to equity). Dividend is not well covered by cash flows (138% cash payout ratio).
Reported Earnings • Aug 03Second quarter 2023 earnings released: EPS: €0.71 (vs €0.95 in 2Q 2022)Second quarter 2023 results: EPS: €0.71 (down from €0.95 in 2Q 2022). Revenue: €128.5m (down 14% from 2Q 2022). Net income: €7.20m (down 25% from 2Q 2022). Profit margin: 5.6% (down from 6.5% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • May 06First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: EPS: €0.76 (down from €0.76 in 1Q 2022). Revenue: €156.0m (up 19% from 1Q 2022). Net income: €7.67m (flat on 1Q 2022). Profit margin: 4.9% (down from 5.9% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.1%. Earnings per share (EPS) also surpassed analyst estimates by 23%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
공시 • May 05AlzChem Group AG to Report First Half, 2023 Results on Aug 03, 2023AlzChem Group AG announced that they will report first half, 2023 results on Aug 03, 2023
Upcoming Dividend • May 05Upcoming dividend of €1.05 per share at 5.5% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. Payout ratio is a comfortable 35% but the company is not cash flow positive. Trailing yield: 5.5%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).
Price Target Changed • Mar 21Price target increased by 8.7% to €29.58Up from €27.20, the current price target is an average from 4 analysts. New target price is 57% above last closing price of €18.85. Stock is down 21% over the past year. The company posted earnings per share of €2.96 last year.
Reported Earnings • Mar 01Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €2.96 (up from €2.72 in FY 2021). Revenue: €566.4m (up 32% from FY 2021). Net income: €30.1m (up 8.9% from FY 2021). Profit margin: 5.3% (down from 6.4% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to €17.85, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 12x in the Chemicals industry in Germany. Total loss to shareholders of 10% over the past three years.
공시 • Dec 09AlzChem Group AG, Annual General Meeting, May 11, 2023AlzChem Group AG, Annual General Meeting, May 11, 2023, at 10:00 Central European Standard Time.
Price Target Changed • Nov 16Price target decreased to €26.05Down from €29.43, the current price target is an average from 4 analysts. New target price is 55% above last closing price of €16.85. Stock is down 28% over the past year. The company is forecast to post earnings per share of €2.40 for next year compared to €2.72 last year.
Reported Earnings • Oct 28Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: €0.59 (up from €0.46 in 3Q 2021). Revenue: €145.1m (up 48% from 3Q 2021). Net income: €5.93m (up 27% from 3Q 2021). Profit margin: 4.1% (down from 4.8% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 18%. Earnings per share (EPS) also surpassed analyst estimates by 69%. Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
공시 • Oct 27AlzChem Group AG to Report Fiscal Year 2022 Final Results on Feb 28, 2023AlzChem Group AG announced that they will report fiscal year 2022 final results at 9:00 AM, Central European Standard Time on Feb 28, 2023
Price Target Changed • Oct 20Price target decreased to €26.05Down from €29.43, the current price target is an average from 4 analysts. New target price is 73% above last closing price of €15.05. Stock is down 33% over the past year. The company is forecast to post earnings per share of €2.55 for next year compared to €2.72 last year.
Reported Earnings • Jul 27Second quarter 2022 earnings released: EPS: €0.95 (vs €0.90 in 2Q 2021)Second quarter 2022 results: EPS: €0.95 (up from €0.90 in 2Q 2021). Revenue: €142.4m (up 26% from 2Q 2021). Net income: €9.59m (up 4.5% from 2Q 2021). Profit margin: 6.7% (down from 8.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 8.7%, compared to a 7.3% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • May 11First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.76 (down from €0.78 in 1Q 2021). Revenue: €133.5m (up 25% from 1Q 2021). Net income: €7.70m (down 2.4% from 1Q 2021). Profit margin: 5.8% (down from 7.4% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 9.9%. Over the next year, revenue is forecast to grow 8.7%, compared to a 6.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Upcoming Dividend • Apr 29Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 06 May 2022. Payment date: 10 May 2022. Payout ratio is a comfortable 37% and this is well supported by cash flows. Trailing yield: 4.5%. Within top quartile of German dividend payers (4.0%). In line with average of industry peers (4.9%).
Reported Earnings • Feb 25Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: €2.72 (up from €1.94 in FY 2020). Revenue: €433.7m (up 12% from FY 2020). Net income: €27.6m (up 40% from FY 2020). Profit margin: 6.4% (up from 5.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 4.1%, compared to a 6.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS €0.46 (vs €0.37 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €98.1m (up 17% from 3Q 2020). Net income: €4.69m (up 25% from 3Q 2020). Profit margin: 4.8% (up from 4.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Price Target Changed • Aug 09Price target increased to €32.25Up from €28.50, the current price target is an average from 2 analysts. New target price is 31% above last closing price of €24.70. Stock is up 23% over the past year.
Reported Earnings • Aug 06Second quarter 2021 earnings released: EPS €0.66 (vs €0.66 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €113.5m (up 6.5% from 2Q 2020). Net income: €9.17m (up 37% from 2Q 2020). Profit margin: 8.1% (up from 6.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year and the company’s share price has also fallen by 6% per year.
Reported Earnings • May 07First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €108.3m (up 13% from 1Q 2020). Net income: €7.89m (up 80% from 1Q 2020). Profit margin: 7.3% (up from 4.6% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • May 06Upcoming dividend of €0.77 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 18 May 2021. Trailing yield: 3.1%. Within top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).
Reported Earnings • Mar 20Full year 2020 earnings released: EPS €1.94 (vs €1.77 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €389.9m (up 1.3% from FY 2019). Net income: €19.7m (up 9.6% from FY 2019). Profit margin: 5.1% (up from 4.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Feb 25New 90-day high: €24.50The company is up 19% from its price of €20.60 on 27 November 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €43.68 per share.
공시 • Jan 16AlzChem Group AG to Report Fiscal Year 2020 Results on Mar 19, 2021AlzChem Group AG announced that they will report fiscal year 2020 results on Mar 19, 2021
Analyst Estimate Surprise Post Earnings • Nov 12Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 16%. Over the next year, revenue is forecast to grow 4.9%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Nov 12Third quarter 2020 earnings released: EPS €0.37The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: €84.1m (down 18% from 3Q 2019). Net income: €3.76m (down 25% from 3Q 2019). Profit margin: 4.5% (down from 4.9% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 78% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
공시 • Nov 07AlzChem Group AG Expands Nitrile Production by 50%AlzChem Group AG consistently continues its growth and investment strategy even in the current environment. Due to the continuing high level of market demand, nitrile production will be expanded by up to 50% by the second quarter of 2021. The investment volume amounts to approximately EUR 12 million. The currently available capacities had only been expanded as of July 2019 and quickly reached 100% capacity. The additional nitrile production capacities are intended to primarily support the growth of medications and biocides. AlzChem takes advantage of the market trend towards more robust supply chains, thus following the trend of increased supply security through a European supplier. The expanded nitrile production plant is again based on AlzChem's proven gas phase technology, which is continuously being optimized by AlzChem engineers and chemists and which sets the standards in terms of raw material yield and environmental aspects.
Is New 90 Day High Low • Oct 30New 90-day low: €17.50The company is down 4.0% from its price of €18.15 on 31 July 2020. The German market is also down 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.80 per share.
공시 • Oct 15AlzChem Group AG Revises Consolidated Sales Guidance for the Fiscal Year 2020AlzChem Group AG revised consolidated sales guidance for the fiscal year 2020. Due to the continuing economic effects of the COVID-19 pandemic in individual target industries and regions, AlzChem Group AG adjusts its forecast for fiscal year 2020. The company now expects to generate stable to slightly declining consolidated sales compared to the previous year (original forecast: slightly rising to sharply rising).
공시 • Oct 01+ 1 more updateAlzChem Group AG to Report First Half, 2021 Results on Aug 05, 2021AlzChem Group AG announced that they will report first half, 2021 results on Aug 05, 2021
공시 • Sep 12AlzChem Group AG to Report Q1, 2021 Results on May 06, 2021AlzChem Group AG announced that they will report Q1, 2021 results on May 06, 2021